The system facilitates simultaneous imaging of coronary arteries with both intravascular ultrasound and optical coherence tomography
Canada-based Conavi Medical has signed agreements to raise more than $20m in funding to support the commercialisation of its Novasight Hybrid System.
It is also planning to raise additional $10m through an ongoing financing.
The company intends to offer its Novasight Hybrid system as a new imaging platform to support interventional cardiologists in minimally invasive heart procedures.